We are live on ! Find out more
PRTC

PureTech Health
PRTC

Delisted

PRTC was delisted on the 20th of May, 2026.

Back to rankings

3 hedge funds and large institutions have $290K invested in PureTech Health in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.03% less ownership

Funds ownership: 0.03% → 0% (-0.03%)

25% less funds holding

Funds holding: 4 → 3 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

84% less capital invested

Capital invested by funds: $1.86M → $290K (-$1.57M)

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
+$209K
2
TRCT
Tower Research Capital (TRC)
New York
+$835

Top Sellers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
-$1.61M
2
Jane Street
Jane Street
New York
-$247K
3
UBS Group
UBS Group
Switzerland
-$163

PRTC Hedge Fund Activity: Q4 2023 in Review

3 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q4 2023, worth a combined $290K — down 84% from $1.86M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PRTC and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $209K. The largest seller was AWM Investment Company, exiting entirely with an estimated $1.61M sold.

  • 3 institutional investors held PureTech Health (PRTC) as of Q4 2023, down from 4 in Q3 2023.
  • Funds reported $290K of PureTech Health stock for Q4 2023, down 84% quarter-over-quarter.
  • 1 fund opened new PureTech Health positions in Q4 2023 and 2 closed out, a net change of -1 holder.
  • The largest PureTech Health buyer in Q4 2023 was Pentwater Capital Management, an estimated $209K added.
  • The largest PureTech Health seller in Q4 2023 was AWM Investment Company, an estimated $1.61M sold.

Based on aggregated 13F filings for Q4 2023.